Trials / Sponsors / Accutar Biotechnology Inc
Accutar Biotechnology Inc
Industry · 6 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies Relapsed/Refractory B-cell Malignancies | Phase 1 | 2023-06-20 |
| Terminated | A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer Metastatic Castration Resistant Prostate Cancer | Phase 1 | 2023-02-22 |
| Active Not Recruiting | Study of AC699 in Patients With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative ( Breast Cancer | Phase 1 | 2022-12-29 |
| Terminated | A Study of AC682 In Chinese Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer Breast Cancer | Phase 1 | 2022-10-01 |
| Terminated | A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer Metastatic Castration Resistant Prostate Cancer | Phase 1 | 2022-03-16 |
| Terminated | A Study of AC682 for the Treatment of Locally Advanced or Metastatic ER+ Breast Cancer Breast Cancer | Phase 1 | 2021-11-12 |